XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Mar 07, 2024 | Option Exercise | $9.85 | 8,641 | 85,114 | 16,824 | Mar 08, 2024, 05:31 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Mar 07, 2024 | Sale | $46.28 | 7,137 | 330,290 | 14,516 | Mar 08, 2024, 05:31 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Mar 07, 2024 | Option Exercise | $45.96 | 1,504 | 69,124 | 15,535 | Mar 08, 2024, 05:31 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Aug 31, 2022 | Option Exercise | $3.13 | 22,488 | 70,443 | 39,720 | Sep 02, 2022, 04:27 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Aug 31, 2022 | Sale | $38.57 | 21,352 | 823,547 | 16,796 | Sep 02, 2022, 04:27 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Sep 01, 2022 | Option Exercise | $38.81 | 6,121 | 237,556 | 60,675 | Sep 02, 2022, 04:27 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Sep 01, 2022 | Option Exercise | $4.75 | 50,000 | 237,500 | 66,796 | Sep 02, 2022, 04:27 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Sep 01, 2022 | Sale | $38.18 | 43,879 | 1,675,476 | 25,572 | Sep 02, 2022, 04:27 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Aug 31, 2022 | Option Exercise | $37.86 | 1,572 | 59,516 | 38,148 | Sep 02, 2022, 04:27 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Mar 04, 2022 | Option Exercise | $31.42 | 696 | 21,868 | 32,770 | Mar 08, 2022, 07:35 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Mar 04, 2022 | Option Exercise | $3.67 | 7,406 | 27,180 | 38,942 | Mar 08, 2022, 07:35 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Mar 04, 2022 | Sale | $30.50 | 21,710 | 662,208 | 32,232 | Mar 08, 2022, 07:35 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | May 28, 2021 | Sale | $18.81 | 6,067 | 114,120 | 35,144 | Jun 01, 2021, 04:11 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | May 28, 2021 | Option Exercise | $18.91 | 4,216 | 79,725 | 38,299 | Jun 01, 2021, 04:11 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | May 28, 2021 | Option Exercise | $3.81 | 25,719 | 97,907 | 40,491 | Jun 01, 2021, 04:11 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Jun 01, 2020 | Option Exercise | $13.70 | 1,630 | 22,331 | 16,796 | Jun 02, 2020, 05:40 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Jun 01, 2020 | Option Exercise | $3.56 | 8,230 | 29,299 | 18,426 | Jun 02, 2020, 05:40 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Sep 12, 2019 | Option Exercise | $3.07 | 6,172 | 18,948 | 12,064 | Sep 13, 2019, 06:58 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Sep 12, 2019 | Option Exercise | $9.38 | 1,868 | 17,522 | 10,196 | Sep 13, 2019, 06:58 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP Bus. & Corp. Development | Mar 15, 2018 | Option Exercise | $4.63 | 1,928 | 8,917 | 5,892 | Mar 16, 2018, 04:33 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | EVP Bus. & Corp. Development | Mar 15, 2018 | Option Exercise | $3.77 | 3,086 | 11,634 | 7,820 | Mar 16, 2018, 04:33 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | SVP Bus. & Corp. Development | May 12, 2017 | Option Exercise | $4.18 | 1,345 | 5,622 | 4,734 | May 16, 2017, 04:32 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | SVP Bus. & Corp. Development | May 12, 2017 | Option Exercise | $3.21 | 2,057 | 6,603 | 6,079 | May 16, 2017, 04:32 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | SVP Bus. & Corp. Development | Dec 16, 2015 | Option Exercise | $5.22 | 411 | 2,145 | 4,251 | Dec 21, 2015, 06:06 AM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | SVP Bus. & Corp. Development | Dec 16, 2015 | Option Exercise | $7.94 | 229 | 1,818 | 4,022 | Dec 21, 2015, 06:06 AM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | SVP Bus. & Corp. Development | Aug 18, 2015 | Option Exercise | $11.00 | 1,302 | 14,322 | 3,840 | Aug 20, 2015, 01:13 PM |
XENE | | Xenon Pharmaceuticals Inc. | ROBIN SHERRINGTON | SVP Bus. & Corp. Development | Aug 18, 2015 | Option Exercise | $4.92 | 3,085 | 15,189 | 4,708 | Aug 20, 2015, 01:13 PM |